Medikamenteninduzierter Diabetes mellitus

Zusammenfassung Zahlreiche Pharmaka können die Glukosehomöostase stören und eine reduzierte Glukosetoleranz oder einen Diabetes mellitus verursachen. Diese Komplikation ist häufig (10–20 %) unter Glukokortikoiden, Statinen, Immunsuppressiva, mehreren Zytostatika sowie HIV-Virostatika. Der medikamenteninduzierte Diabetes entspricht meistens einem Typ-2-Diabetes, aber auch insulinpflichtiger Autoimmundiabetes ist nach Interferon alpha oder einer Tumorimmuntherapie beschrieben. Der medikamenteninduzierte Diabetes muss therapeutische Konsequenzen haben, selbst wenn die Hyperglykämie moderat ist, da mit Sekundärkomplikationen des Diabetes gerechnet werden muss.

• Publication year

  2019

• Venue

  Diabetes aktuell

• Publication date

  2019-08-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1055/A-0916-0563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of anti-somatostatin agents on glucose metabolism.

  2017cited by this paper
• Acute Hyperglycemia Associated with Anti-Cancer Medication

  2017cited by this paper
• Long-Standing Problem of β-Blocker-Elicited Hypoglycemia in Diabetes Mellitus.

  2017cited by this paper
• Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV‐infected patients? A meta‐analysis

  2017cited by this paper
• Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.

  2015cited by this paper
• Drug-Induced Hyperglycaemia and Diabetes

  2015cited by this paper
• Interferon therapy in hepatitis C leading to chronic type 1 diabetes.

  2015cited by this paper
• Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review

  2014cited by this paper
• Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-Analysis

  2014cited by this paper
• Effect of calcium channel blockers on incidence of diabetes: a meta-analysis

  2013cited by this paper
• Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

  2010cited by this paper
• The metabolic syndrome in overweight epileptic patients treated with valproic acid

  2010cited by this paper
• Dysglycaemias and Fluoroquinolones

  2008cited by this paper
• New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis

  2004cited by this paper
• Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes

  2003cited by this paper
• Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes.

  2003cited by this paper

• No citing papers are available for this paper.